These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34751641)

  • 1. Retrospective evaluation of routine whole genome sequencing of
    Soetaert K; Ceyssens PJ; Boarbi S; Bogaerts B; Delcourt T; Vanneste K; De Keersmaecker SCJ; Roosens NHC; Vodolazkaia A; Mukovnikova M; Mathys V
    Acta Clin Belg; 2022 Oct; 77(5):853-860. PubMed ID: 34751641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of whole genome sequencing versus phenotypic (MGIT) and commercial molecular tests for detection of drug-resistant Mycobacterium tuberculosis isolated from patients in Brazil and Mozambique.
    Feliciano CS; Namburete EI; Rodrigues Plaça J; Peronni K; Dippenaar A; Warren RM; Silva WA; Bollela VR
    Tuberculosis (Edinb); 2018 May; 110():59-67. PubMed ID: 29779775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, France.
    Genestet C; Hodille E; Berland JL; Ginevra C; Bryant JE; Ader F; Lina G; Dumitrescu O;
    Int J Antimicrob Agents; 2020 Apr; 55(4):105912. PubMed ID: 31991222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic efficacy of an optimized nucleotide MALDI-TOF-MS assay for anti-tuberculosis drug resistance detection.
    Ou X; Song Z; Zhao B; Pei S; Teng C; Zheng H; He W; Xing R; Wang Y; Wang S; Xia H; Zhou Y; He P; Zhao Y
    Eur J Clin Microbiol Infect Dis; 2024 Jan; 43(1):105-114. PubMed ID: 37980301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the clinical impact of routine whole genome sequencing in tuberculosis treatment decisions and the issue of isoniazid mono-resistance.
    Park M; Lalvani A; Satta G; Kon OM
    BMC Infect Dis; 2022 Apr; 22(1):349. PubMed ID: 35392842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium tuberculosis complex whole-genome sequencing in New York State: Implementation of a reduced phenotypic drug susceptibility testing algorithm.
    Shea J; Halse TA; Modestil H; Kearns C; Fowler RC; Da Costa-Carter CA; Siemetzki-Kapoor U; Leisner M; Lapierre P; Kohlerschmidt D; Rowlinson MC; Escuyer V; Musser KA
    Tuberculosis (Edinb); 2023 Sep; 142():102380. PubMed ID: 37543009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WGS more accurately predicts susceptibility of Mycobacterium tuberculosis to first-line drugs than phenotypic testing.
    Jajou R; van der Laan T; de Zwaan R; Kamst M; Mulder A; de Neeling A; Anthony R; van Soolingen D
    J Antimicrob Chemother; 2019 Sep; 74(9):2605-2616. PubMed ID: 31119271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct Whole-Genome Sequencing of Sputum Accurately Identifies Drug-Resistant Mycobacterium tuberculosis Faster than MGIT Culture Sequencing.
    Doyle RM; Burgess C; Williams R; Gorton R; Booth H; Brown J; Bryant JM; Chan J; Creer D; Holdstock J; Kunst H; Lozewicz S; Platt G; Romero EY; Speight G; Tiberi S; Abubakar I; Lipman M; McHugh TD; Breuer J
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29848567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of the REBA MTB-Rifa® assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis.
    Cho E; Shamputa IC; Kwak HK; Lee J; Lee M; Hwang S; Jeon D; Kim CT; Cho S; Via LE; Barry CE; Lee JS
    BMC Infect Dis; 2013 Oct; 13():478. PubMed ID: 24128118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
    Maningi NE; Malinga LA; Antiabong JF; Lekalakala RM; Mbelle NM
    BMC Infect Dis; 2017 Dec; 17(1):795. PubMed ID: 29282012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence and transmission of pyrazinamide-resistant
    Liu BB; Hu PL; Chen ZH; Yi SL; Zhang XP; Tan YH
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Jul; 45(7):677-685. PubMed ID: 35768376
    [No Abstract]   [Full Text] [Related]  

  • 12. Accuracy of a reverse dot blot hybridization assay for simultaneous detection of the resistance of four anti-tuberculosis drugs in Mycobacterium tuberculosis isolated from China.
    Wan L; Guo Q; Wei JH; Liu HC; Li MC; Jiang Y; Zhao LL; Zhao XQ; Liu ZG; Wan KL; Li GL; Guan CX
    Infect Dis Poverty; 2020 Apr; 9(1):38. PubMed ID: 32299480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multicenter evaluation of the indirect nitrate reductase assay for the rapid detection of multidrug-resistant tuberculosis].
    Çoban AY; Taştekin B; Uzun M; Kalaycı F; Ceyhan İ; Biçmen C; Albay A; Sığ AK; Özkütük N; Sürücüoğlu S; Özkütük A; Esen N; Albayrak N; Aslantürk A; Sarıbaş Z; Alp A
    Mikrobiyol Bul; 2016 Jan; 50(1):140-6. PubMed ID: 27058338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a membrane hybridization array for detection of Mycobacterium tuberculosis complex and resistance to isoniazid and rifampin in sputum specimens, mycobacterial liquid cultures, and clinical isolates.
    Chen CJ; Yang YC; Huang HH; Chang TC; Lu PL
    Kaohsiung J Med Sci; 2019 Oct; 35(10):615-623. PubMed ID: 31433118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct detection of Mycobacterium tuberculosis and drug resistance in respiratory specimen using Abbott Realtime MTB detection and RIF/INH resistance assay.
    Tam KK; Leung KS; To SW; Siu GK; Lau TC; Shek VC; Tse CW; Wong SS; Ho PL; Yam WC
    Diagn Microbiol Infect Dis; 2017 Oct; 89(2):118-124. PubMed ID: 28780247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-genome sequencing analysis of multidrug-resistant
    Tania T; Sudarmono P; Kusumawati RL; Rukmana A; Pratama WA; Regmi SM; Kaewprasert O; Chaiprasert A; Chongsuvivatwong V; Faksri K
    J Med Microbiol; 2020 Jul; 69(7):1013-1019. PubMed ID: 32579102
    [No Abstract]   [Full Text] [Related]  

  • 17. Prediction of drug resistance by Sanger sequencing of Mycobacterium tuberculosis complex strains isolated from multidrug resistant tuberculosis suspect patients in Ethiopia.
    Mesfin EA; Merker M; Beyene D; Tesfaye A; Shuaib YA; Addise D; Tessema B; Niemann S
    PLoS One; 2022; 17(8):e0271508. PubMed ID: 35930613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of drug resistance profile of multidrug-resistant Mycobacterium tuberculosis (MDR-MTB) isolates from newly diagnosed case by whole genome sequencing (WGS): a study from a high tuberculosis burden country.
    Sun W; Gui X; Wu Z; Zhang Y; Yan L
    BMC Infect Dis; 2022 May; 22(1):499. PubMed ID: 35624432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Pyrazinamide Resistance in Khyber Pakhtunkhwa, Pakistan.
    Khan MT; Malik SI; Ali S; Sheed Khan A; Nadeem T; Zeb MT; Masood N; Afzal MT
    Microb Drug Resist; 2018 Nov; 24(9):1417-1421. PubMed ID: 29584579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study.
    Pankhurst LJ; Del Ojo Elias C; Votintseva AA; Walker TM; Cole K; Davies J; Fermont JM; Gascoyne-Binzi DM; Kohl TA; Kong C; Lemaitre N; Niemann S; Paul J; Rogers TR; Roycroft E; Smith EG; Supply P; Tang P; Wilcox MH; Wordsworth S; Wyllie D; Xu L; Crook DW;
    Lancet Respir Med; 2016 Jan; 4(1):49-58. PubMed ID: 26669893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.